Literature DB >> 9512940

Metabolism of (-)-(S)-nicotine in the isolated perfused rabbit lung.

G Aislaitner1, A Bello, S C Tan, A J Hutt, C Marriott, J W Gorrod.   

Abstract

The metabolism of (-)-(S)-nicotine has been investigated following intratracheal administration to the recirculating perfused rabbit lung model. The metabolic products present in the perfusate were identified by co-chromatography (HPLC and GC) with authentic standards and quantified by HPLC. After the 180 min perfusion period, nicotine was found to be metabolically transformed to cotinine (33.7%), 3-hydroxycotinine (10.4%), cotinine-1-N-oxide (3.4%) and nicotine-1'-N-oxide (14.4%). Norcotinine, nornicotine, 3-pyridyl-4-oxo-N-methylbutyramide and an uncharacterised metabolite were also detected in low amounts. Following the perfusion experiment, part of the lung tissue was homogenised in the presence of [14C]-sodium cyanide. Subsequent analysis of the homogenates indicated the formation of 2'-cyanonicotine, 1'-cyanomethylnornicotine and the diastereoisomeric 5'-cyanonicotines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9512940     DOI: 10.1007/BF03190976

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  15 in total

1.  Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation.

Authors:  J W Gorrod; C M Whittlesea; S P Lam
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  The metabolism of nicotine into two optically-active stereoisomers of nicotine-1'-oxide by animal tissues in vitro and by cigarette smokers.

Authors:  J Booth; E Boyland
Journal:  Biochem Pharmacol       Date:  1970-03       Impact factor: 5.858

3.  Nicotine metabolism in isolated perfused lung and liver of phenobarbital- and benzoflavone-treated rats.

Authors:  H Foth; H Looschen; H Neurath; G F Kahl
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  Pharmacokinetics of amiodarone in the isolated rat lung.

Authors:  P Camus; B Coudert; P D'Athis; M Dumas; A Escousse; L Jeannin
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

5.  The metabolism of nicotine-delta 1'(5')-iminium ion, in vivo and in vitro.

Authors:  J W Gorrod; A R Hibberd
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

6.  Metabolic oxidation of nicotine to chemically reactive intermediates.

Authors:  T L Nguyen; L D Gruenke; N Castagnoli
Journal:  J Med Chem       Date:  1979-03       Impact factor: 7.446

7.  Pulmonary sequestration of amiodarone and desethylamiodarone.

Authors:  P Camus; H M Mehendale
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

8.  The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung.

Authors:  D E Williams; M K Shigenaga; N Castagnoli
Journal:  Drug Metab Dispos       Date:  1990 Jul-Aug       Impact factor: 3.922

9.  N-hydroxymethylnorcotinine, a new primary in vitro metabolite of cotinine.

Authors:  Y Li; J W Gorrod
Journal:  Xenobiotica       Date:  1994-05       Impact factor: 1.908

Review 10.  The metabolism of alicyclic amines to reactive iminium ion intermediates.

Authors:  J W Gorrod; G Aislaitner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

View more
  2 in total

1.  Nicotine metabolism in pregnant and nonpregnant rabbits.

Authors:  Piotr Tutka; Delia A Dempsey; Peyton Jacob; Neal L Benowitz; Deanna L Kroetz
Journal:  Nicotine Tob Res       Date:  2008-08       Impact factor: 4.244

2.  Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network.

Authors:  Tyler B Hughes; Na Le Dang; Grover P Miller; S Joshua Swamidass
Journal:  ACS Cent Sci       Date:  2016-07-29       Impact factor: 14.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.